Clinical Trials Directory

Trials / Completed

CompletedNCT03675646

Spinal Morphine for Postoperative Analgesia in Urology

Comparison of Spinal Morphine With Systemic Analgesia After Urologic Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study was performed in urology patients elicited for open prostatectomy or open nephrectomy. Comparison of analgesic effect between group (M) with spinal morphine before general anaesthesia and group without this intervention was measured.

Detailed description

Patients elicited for open prostatectomy or open nephrectomy were randomly divided in 2 groups. Group M were administered preservative-free morphine 250 mcg in 2.5 ml NS intrathecal using 25 G needle in L1/2 - L5/S1 interspaces. Control group (C) were given no intervention. Placebo intrathecal injection in C was not used because of ethical reason. Standard general anaesthesia was used in both groups. After surgery all patients were transferred to urology ICU and were given standard analgesic regimen according to level of pain measured by numeric rating scale (NRS) 0 - 10: NRS \> 3 metamizol 1 g IV every 6 h., max. 4 g/24 h., NRS \> 3 paracetamol 1g IV every 6 h., max. 4 g/24 h., NRS \> 3 lasting 30 min. after administration of previous ones diclofenac 75 mg IM á 12 h., max. 150 mg/24 h., NRS \> 4 morphine 10 mg SC á 6 h. Personnel of ICU was blinded to the analgesic method used. Noticed parameters: pain intensity (NRS), time to NRS ≥ 4, time to the first morphine request, side effects (respiratory rate \<8, SpO2\<90 %, nausea, vomiting, naloxone administration for SpO2\<88 %, itching). Standard statistical analysis was used, p value \< 0.05 was considered significant.

Conditions

Interventions

TypeNameDescription
DRUGMorphineIntrathecal injection of 250 mcg preservative-free morphine before surgery

Timeline

Start date
2016-03-05
Primary completion
2017-06-30
Completion
2017-07-10
First posted
2018-09-18
Last updated
2018-09-19

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT03675646. Inclusion in this directory is not an endorsement.